Loomis Sayles & CO L P Exact Sciences Corp Transaction History

Loomis Sayles & CO L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $100,610 - $131,900	-1,788 Reduced 0.47%	377,835 $26.1 Million
Q4 2023 Feb 13, 2024	SELL	$59.06 - $75.72 $102,114 - $130,919	-1,729 Reduced 0.45%	379,623 $28.1 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $4.33 Million - $6.5 Million	65,675 Added 20.8%	381,352 $26 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $19.7 Million - $29.9 Million	314,743 Added 33698.39%	315,677 $29.6 Million
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $19,253 - $28,874	408 Added 77.57%	934 $63,000
Q4 2022 Feb 10, 2023	BUY	$30.35 - $53.15 $15,964 - $27,956	526 New	526 $26,000
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $10,491 - $13,950	-90 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $8,964 - $12,790	90 New	90 $12,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.